Cargando…
Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method
Breast cancer brain metastasis (BCBM) remains a major clinical problem. Approximately 10–16% of patients with breast cancer develop brain metastases (BCBM). However, no systemic therapy has gained regulatory approval for the specific treatment of BCBM and this remains an area of persistent, unmet me...
Autores principales: | Liu, Zongming, Wang, Yanzhi, Kabraji, Sheheryar, Xie, Shaozhen, Pan, Peichen, Liu, Zhenning, Ni, Jing, Zhao, Jean J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346002/ https://www.ncbi.nlm.nih.gov/pubmed/30679540 http://dx.doi.org/10.1038/s41598-018-36874-3 |
Ejemplares similares
-
THER-12. PRECLINICAL EVALUATION OF NERATINIB PLUS T-DM1 IN ORTHOTOPIC PDX MODELS OF HER2-POSITIVE BREAST CANCER BRAIN METASTASES
por: Ni, Jing, et al.
Publicado: (2019) -
p16(INK4A)-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases
por: Ni, Jing, et al.
Publicado: (2022) -
Intracarotid amobarbital disrupts synchronous and nested oscillatory activity ipsilateral to injection()
por: Young, James J., et al.
Publicado: (2018) -
The impact of cannabis use on intracarotid amobarbital testing
por: Domen, Christopher H., et al.
Publicado: (2019) -
Porcine model of neurocysticercosis by intracarotid injection of Taenia solium oncospheres: Dose assessment, infection outcomes and serological responses
por: Arroyo, Gianfranco, et al.
Publicado: (2022)